ArticleClinical kidney journal2022

The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis.

Smeeta Sinha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.